Liquidia Corporation

LQDA·NasdaqCM·Healthcare
Compare
47.38+5.18 (+12.27%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market48.23+0.85 (+1.79%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close42.20
Open43.32
Day range43.2451.11
52-week range22.3193.61
Off day high−7.30%
Off 52-week high−49.39%
Volume4.81M
Avg. volume (3M)3.42M
Market cap4.24B
EPS (TTM)1.39
Forward P/E21.66
P/E ratio (TTM)34.09
Dividend yield—
Beta (5Y)0.41
Shares outstanding89.51M
Short interest23.98% of float
Earnings dateNov 10, 2026
Analyst target54.38
Profit margin30.74%

Against its peers

Compare in full ›
LQDA LNTH UTHR 2M7C.F 0950.HK 1513.HK
Market cap 4.24B 6.60B 26.10B 2.87B 638.89M 21.49B
P/E (TTM) 34.1 24.5 23.0 14.8 5.4 12.1
Forward P/E 21.7 15.6 18.0 — 7.8 9.1
Price/book 21.6 5.0 3.7 1.2 0.3 1.4
Dividend yield — — — 3.42% 6.51% 6.82%
1-year change +59.73% +76.13% +34.39% −28.57% −41.58% −24.47%
Today +12.27% +0.34% +1.19% +2.61% +0.93% +0.50%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All LQDA news ›
Trefis·

What Is Behind Liquidia’s Lead Over Its Industry?

Over the past five years, one drugmaker outperformed all 60 of its measurable pharmaceutical peers. That company is Liquidia Corporation (LQDA) (LQDA), the manufacturer of YUTREPIA, an inhalation powder form of the drug treprostinil.…

Seeking Alpha·Positive

Liquidia Is A Bargain Today

Arquitos Capital details Liquidia's legal settlement with United Therapeutics and its path forward. Read the full analysis for more details. - Liquidia will pay a net of $380.7 million in multiple installments in 2026 and 2027. - The…

From the 4Search news index, newest first.

In the news

104mentions in 30 days
87with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 104 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance